Perceptions of cisplatin-related toxicity among ovarian cancer patients and gynecologic oncologists

Gynecologic Oncology

Volumn 71, Issue 3, 1998, Pages 369-375

  Calhoun, Elizabeth A ^a   Bennett, Charles L ^a   Peeples, Patti A ^b   Lurain, John R ^a   Roland, Philip Y ^a   Weinstein, Jill M ^a   Fishman, David A ^a,c  

^a NORTHWESTERN UNIVERSITY   (United States)

^b ALZA CORPORATION   (United States)

^c NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN;

ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CLINICAL ARTICLE; DRUG CHOICE; DRUG MONITORING; FEMALE; HUMAN; NEPHROTOXICITY; NEUROTOXICITY; OTOTOXICITY; OVARY CANCER; PRIORITY JOURNAL; RISK BENEFIT ANALYSIS; TREATMENT PLANNING;

EID: 0032408516     PISSN: 00908258     EISSN: None     Source Type: Journal    
DOI: 10.1006/gyno.1998.5189     Document Type: Article

References (35)

1. 1. Facts about Cancer, American Cancer Society, 1997
2. 2. Nehemkis AM, Gerber KE, Charter RA: The cancer ward: patient perceptions-staff misperceptions. Psychother Psychosomat 41:42-47, 1984
3. 3. Sneeuw K, Aaronson NK, Sprangers M, et al.: Value of caregiver ratings in evaluating the quality of life of patients with cancer. J Clin Oncol 15(3):1206-1217, 1997
4. 4. Mackillop WJ, O'Sullivan B, Ward GK: Non-small cell lung cancer: how oncologists want to be treated. Int J Radiat Oncol Biol Phys 13:929-934, 1987
5. 5. Bremnes RM, Andersen K, Wist EA: Cancer patients, doctors, and nurses vary in their willingness to undertake cancer chemotherapy. Eur J Cancer 31A(12): 1955-1959, 1995
6. 6. Van der Donk J, Levendag PC, Kuijpers AJ, et al.: Patient participation in clinical decision-making for treatment of T3 laryngeal cancer: a comparison of state and process utilities. J Clin Oncol 13(9):2369-2378, 1995
7. 7. Yellen SB, Cella DF, Leslie WT: Age and clinical decision making in oncology patients. JNCI 86(23):1766-1770, 1994
8. 8. Daugerty C, Ratain MJ, Grochowski E, Stocking C, Kodish E, Mick R, Siegler M: Perceptions of patients and their physicians involved in phase I trials. J Clin Oncol 13:1062-1072, 1995
9. 9. Grossman SA, Sheidler VR, Sweedeen K, et al.: Correlation of patient and caregiver ratings of cancer pain. J Pain Symptoms Manage 6(2):53-57, 1991
10. 10. Hodgkins M, Albert D, Daltroy L: Comparing patients' and their physicians' assessments of pain. Pain 273-277, 1985
11. 11. Boyd NF, Sutherland HJ, Heasman KZ, et al.: Whose utilities for decision analysis? Med Decision Making 10:58-67, 1990
12. 12. Llewellyn-Thomas HA, Sutherland HJ, Thiel EC: Do patients' evaluations of a future health state change when they actually enter that state? Med Care 31:1002-1012, 1993
13. 13. Slevin ML, Plant H, Lynch D, Drinkwater J, Gregory WM: Who should measure quality of life, the doctor or the patient? Br J Cancer 57:109-112, 1988
14. 14. Lindley CM, Vasa SP, Sawyer WT, and Winer EP: Eliciting differences for adjuvant therapy in patients with early stage breast cancer: tradeoffs between treatment, cure, and survival. ASCO abstract, 1995
15. 15. Gold MR, Siegel JE, Russell LB, Weinstein MC: Cost-Effectiveness in Health and Medicine. Oxford, Oxford University Press, 1996
16. 16. Hayman JA, Fairclough DL, Harris JR, Weeks JC: Patient preferences concerning the trade-off between the risks and benefits of routine radiation therapy after conservative surgery for early-stage breast cancer. J Clin Oncol 15(3):1252-1260, 1997
17. 17. Nelson EC, Berwick DM: The measurement of health status in clinical practice. Med Care 27(suppl):S77-S90, 1989
18. 18. Schor EL, Lerner DJ, Malspeis S: Physicians' assessment of functional status and well-being: the patient's perspective. Arch Intern Med 155: 309-314, 1995
19. 19. Pearlman RA, Uhlmann RF, Jecker NS: Spousal understanding of patient quality of life: implications for surrogate decisions. J Clin Ethics 3:114-121, 1992
20. 20. Samet J, Hunt WC, Key C, Humble CG, Goodwin JS: Choice of cancer therapy varies with age patient. JAMA 257:2766-2770, 1987
21. 21. Greenfield S, Blanco DM, Elashoff RM, Ganz PA: Pattern of care related to age of breast cancer patients. JAMA 257:2766-2770, 1987
22. 22. Grover SA, Cook EF, Adam J, Coupal L, Goldman L: Delayed diagnosis of gynecological tumors in elderly women: relation to national medical practice patterns. Am J Med 86:151-157, 1989
23. 23. Greenburg ER, Chute CG, Stukel T, et al.: Social and economic factors in the choice of lung cancer treatment. A population-based study in two rural states. N Engl J Med 86:151-157, 1989
24. 24. Kong A, Barnett GO, Mosteller F, Yountz C: How medical professionals evaluate expression of probability. N Engl J Med 315:740-744, 1986
25. 25. Hunter CP, Frelick RW, Feldman AR, et al.: Selection factors in clinical trials: results from the community clinical oncology program physician's patient log. Cancer Treat Rep 71:559-565, 1987
26. 26. Obrist R, Honegger HP, Pichert G, Senn HJ: Physicians' attitudes in the treatment of elderly patients with aggressive NHL. Ann Oncol 3(suppl 5): 123, 1992
27. 27. Schleifer SJ, Bhardwaj S, Lebovits A, Tanaka JS, Messe M, Strain JJ: Predictors of physician nonadherence to chemotherapy regimens. Cancer 67:945-951, 1991
28. 28. Cassileth BR, Zupkis RV, Sutton-Smith K, March V: Information and participation preferences among career patients. Ann Intern Med 92:823-836, 1980
29. 29. Kodiath MF, Kodiath EA: A comparative study of patients who experience chronic malignant pain in India and the United States. Cancer Nursing 18(3):189-196, 1995
30. 30. McNeil BJ, Weichselbaum R, Pauker SG: Fallacy of the five year survival in lung cancer. N Engl J Med 299:1395-1401, 1978
31. 31. Brock D: Quality of Life Measures in Health Care and Medical Ethics. In Nussbaum M, Sens A (eds): The Quality of Life. Oxford, Clarendon Press, 1993
32. 32. Hornberger J, Lenert LA: Variation among quality of life surveys: theory and practice. Med Care 34:DS23-DS33, 1996
33. 33. Bennett CL, McCrory D, Matchar D: Cost effective models for flutamide for prostate carcinoma patients. Cancer 77:1854-1861, 1996
34. 34. Drummond MF, O'Brien B, Stoddart GL, Torrance GW: Methods for the Economic Evaluation of Health Care Programmes, 2nd ed, Oxford, Oxford University Press, 1997
35. 35. Torrance GW, Thomas W, Sackett D: A utility maximization model for evaluation of health care programs. Health Serv Res 7(2) Summer:118-133, 1972